Guangdong VTR Bio-Tech's (SHE:300381) unit, Hunan Kangjie Biotechnology, agreed to sell equipment to Huasai Biotechnology (Changde) for 35.8 million yuan, according to a Shenzhen Stock Exchange disclosure on Tuesday.
The transferred equipment included 44 types of exclusive equipment, such as flat-plate scraper unloading automatic centrifuge and steel-lined PE ion exchange column diaphragm filter press, the Chinese manufacturer of feed additives and veterinary medicine powder said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。